Work

Reply:

Year: 2022

Type: letter

Abstract: In the commentary “MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?” Høilund-Carlsen et al provide their viewpoint on the efficacy of monoclonal antibody therapies (mAbs) targeting beta-amyloid and the appropriate imaging for treatment

Source: American Journal of Neuroradiology

DOI: 10.3174/ajnr.a7731

Authors: P.M. Cogswell, C.R. Jack, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.A. Raji, T.Y. Poussaint, V.K. Ramanan, C.T. Whitlow

Institutions: Mayo Clinic, California Pacific Medical Center, UCL Queen Square Institute of Neurology, University College London, Amsterdam UMC Location Vrije Universiteit Amsterdam, Washington University in St. Louis, Boston Children's Hospital, Wake Forest University Health Sciences, Wake Forest University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funder: National Institute on Aging

Awards: Dominantly Inherited Alzheimer Network, Healthy Aging and Senile Dementia, Dominantly Inherited Alzheimer Network

OpenAlex ID: W4311888170

Cites: 2

Cited by: 1

Related to: 10